Advanced Diagnostics and Monitoring for Hepatocellular Carcinoma

Description

This comprehensive session, developed in partnership with the American Society for Clinical Oncology (ASCO), addresses the latest advancements in hepatocellular carcinoma (HCC) diagnosis and monitoring, with a special focus on molecular-based targeted therapies, ctDNA and pioneering imaging techniques like immuno-PET and MR spectroscopy. Participants will gain a deeper understanding of how ctDNA analysis can improve not only HCC diangosis but prognosis and treatment monitoring. We will also explore the role of radiomics, and novel imaging modalities such as immuno-PET and MR spectroscopy, in improving the accuracy of HCC diagnosis and treatment planning. The session bridges critical knowledge gaps by showing the potential integration of these advanced technologies into personalized patient management.